BOMESI Foundation Opens Fifth Accelerator Cohort For Diverse-Owned Media Publishers And Creators 
Ynvisible Advances Commercial Program with Sapphiros, Announces CFO Appointment and Adoption of Semi-Annual Financial Reporting 
Airwheel SE3SX AI Wheel Luxury Suitcase Wins 2026 WGA for Smart Electric Riding Carry-On Hand Luggage 
Syntheia Signs Definitive Agreement for Sale of Call Center Assets and Announces Shares for Debt Transaction Rapid Therapeutic Science Laboratories to Present at the Benzinga Global Small Cap Conference
DALLAS, Dec. 02, 2021 (GLOBE NEWSWIRE) — Rapid Therapeutic Science Laboratories (OTC: RTSL) (“Rapid Therapeutic”…
Biofrontera Inc. Announces Notice of Allowance for U.S. Patent on Innovative Illumination Protocol
WOBURN, Mass., Dec. 02, 2021 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company…
Bespoke Extracts to Acquire Colorado Based Wonderleaf, LLC
Transaction provides Bespoke with a licensed marijuana infused production facility in Colorado. DENVER, Colorado., Dec….
Rubius Therapeutics Named to the List of Top Places to Work in Massachusetts by the Boston Globe and Top 3 Best Places to Work in Rhode Island by Providence Business News
Company Earns Spot on Both Lists for Second Year in a Row CAMBRIDGE, Mass., Dec….
Berkeley Lights Debuts in France as MImAbs Acquires the Beacon® Optofluidic System for Antibody Discovery
EMERYVILLE, Calif. and MARSEILLE, France, Dec. 02, 2021 (GLOBE NEWSWIRE) — Berkeley Lights, Inc. (Nasdaq:…
Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present on Advances in Utilizing CRISPR Genome Editing to Increase Seed Oil Content in Camelina at Canola Week Conference
WOBURN, Mass., Dec. 02, 2021 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience…
Albireo Expands Leadership with Constantine Chinoporos as Chief Business Officer
– New chief business officer to oversee Company’s corporate and business development strategy – BOSTON,…
Manitoba Harvest Introduces Hemp Hearts Health Hack to Thrive During the Holidays
78% of People Surveyed Want More Holistic Health Support This Season Manitoba Harvest. Manitoba Harvest….
ARCA biopharma Announces Completion of Enrollment in Phase 2b ASPEN-COVID-19 Clinical Trial Evaluating rNAPc2 as a Potential Treatment for Patients Hospitalized with COVID-19
Dr. Bristow Dr. Michael Bristow, President and CEO, ARCA biopharma, Inc. Topline readout of clinical…
Codiak’s Engineered Exosomes Promote T Cell and Antibody Responses to SARS-CoV-2 in vivo, Supporting the Potential for a Broadly Protective Pan-Beta Coronavirus and Variant Vaccine
Preclinical data at World Vaccine & Immunotherapy Congress 2021 show broad immunogenicity and neutralization against…
Mindset Pharma to Participate in Stifel GMP’s The Future of Healthcare Conference on December 8th
TORONTO, Dec. 02, 2021 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB:…
Dyne Therapeutics Announces Submission of IND Application to Initiate Clinical Trial of DYNE-251 for Duchenne Muscular Dystrophy
– DYNE-251, Dyne’s First DMD Program, is Being Developed for Patients with Mutations Amenable to…
Medexus Pharmaceuticals Announces Clear Path to FDA Decision Following medac’s Type A Meeting with FDA on Treosulfan
NDA resubmission expected in second calendar quarter 2022 (previously anticipated timeline)Final FDA decision expected 2 to…
SOTIO Secures €280m of Funding to Expand and Advance Clinical Pipeline
PPF Group provides funding to advance SOTIO through key clinical milestones Proceeds shall be used…
Immutep Reports Good Safety from First Five Patients in Triple Combination Therapy Efti Study, Insight-003
SYDNEY, AUSTRALIA, Dec. 02, 2021 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep”…
Cocrystal Pharma to Discuss Progress with COVID-19 Antiviral Programs and Clinical Strategy During Noble Capital Markets’ Channelchek Virtual Roadshow
BOTHELL, Wash., Dec. 02, 2021 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or…
Certara Announces Release of Simcyp™ Simulator Version 21, Expanding Capabilities to Align with Recent Regulatory Guidances
Simcyp Simulator has been used to inform more than 250 label claims for 85+ novel…
Replimune Appoints Christy Oliger to its Board of Directors
WOBURN, Mass., Dec. 02, 2021 (GLOBE NEWSWIRE) — Replimune Group, Inc. (Nasdaq: REPL), a biotechnology…
Acepodia Raises $109 Million Series C Financing to Advance Development of First-in-Class Antibody Cell Effector Therapies
Visionary technology investor Samuel Chen to join Board of Directors ALAMEDA, Calif., Dec. 02, 2021…
GBT Supports the ASH Research Collaborative’s Data Hub Sickle Cell Disease Program
Grant of $400,000 to help expand sickle cell disease real-world data gathering in the U.S….